Results 21 to 30 of about 9,263,948 (394)

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

open access: yesJournal of the American Medical Association (JAMA), 2003
CONTEXT Second cancer is the leading cause of death in long-term survivors of Hodgkin disease (HD), with exceptionally high risks of breast cancer among women treated at a young age.
L. Travis   +17 more
semanticscholar   +1 more source

Relationship between quality of life indicators and cardiac status indicators in chemotherapy patients

open access: yesSlovenian Journal of Public Health, 2021
With the aim of improving personalized treatment of patients on chemotherapy, the objective of the study was to assess the degree of association between selected Quality of life (QoL) indicators and both clinical and imaging cardiac status indicators ...
Geršak Blaž Matija   +12 more
doaj   +1 more source

Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019 [PDF]

open access: yesYixue xinzhi zazhi, 2021
Objective To analyze the epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019. Methods Based on data from the Global Burden of Disease 2019 survey (GBD 2019), we used incidence, mortality, disability-adjusted ...
Wen-Tao WU   +5 more
doaj   +1 more source

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1994
Hodgkin disease (HD) is characterized by a small number of putative malignant cells [Hodgkin and Reed-Sternberg (HRS) cells] among a background of lymphocytes and histiocytes.
R. Küppers   +6 more
semanticscholar   +1 more source

Use of Rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas [PDF]

open access: yes, 2011
The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. Also autoimmune hemolytic anemia (AHA), although much more frequent in patients with chronic lymphocytic leukemia (CLL), has been described in this group of ...
Fozza, Claudio   +1 more
core   +4 more sources

Hodgkin's Disease [PDF]

open access: yesNew England Journal of Medicine, 1979
During the past two decades, new approaches to the diagnosis and treatment of Hodgkin's disease have contributed to improved rates of survival and probable cure. Currently, patients with Hodgkin's disease are treated according to the stage and symptoms of their disease.
Anthony T. Piro   +2 more
openaire   +6 more sources

Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons

open access: yesCell Reports, 2023
Summary: Variants at the GBA locus, encoding glucocerebrosidase, are the strongest common genetic risk factor for Parkinson’s disease (PD). To understand GBA-related disease mechanisms, we use a multi-part-enrichment proteomics and post-translational ...
Helle Bogetofte   +22 more
doaj  

Approach of the patient with generalized adenopathies. Importance of the didactic strategy of the study of clinical cases: a purpose of a patient with Hodgkin’s lymphoma associated with an infection with the Epstein-Barr virus

open access: yesIatreia, 2019
We present the case of a 56-year-old patient with a generalized adenomegalic syndrome who presented a mixed cellular Hodgkin’s lymphoma associated with Epstein Barr Virus.
Villegas Molina, Juan Pablo   +9 more
doaj   +1 more source

Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma : endpoints of a spectrum of one disease? [PDF]

open access: yes, 2013
In contrast to the commonly indolent clinical behavior of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T cell/histiocyte rich large B cell lymphoma (THRLBCL) is frequently diagnosed in advanced clinical stages and has a poor prognosis ...
Döring, Claudia   +13 more
core   +3 more sources

Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma

open access: yesCancer Management and Research, 2021
Reyizha Nuersulitan,1 Mingzi Yang,1 Lan Mi,1 Meng Wu,1 Xin Liu,2 Lingyan Ping,1 Yan Xie,1 Weiping Liu,1 Yuqin Song,1 Jun Zhu1 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University ...
Nuersulitan R   +9 more
doaj  

Home - About - Disclaimer - Privacy